According to a new report Europe Urinary Incontinence Devices Market, published by KBV research, the Europe Urinary Incontinence Devices Market would witness market growth of XX% CAGR during the forecast period (2018 – 2024).
The Germany market dominated the Europe Stress Incontinence Market by Country in 2017; thereby, achieving a market value of $87 million by 2024, The UK market is expected to witness a CAGR of 9% during (2018 - 2024). Additionally, The France market is expected to witness a CAGR of 11.5% during (2018 - 2024).
The Internal Urinary Incontinence Devices market dominated the Europe Urinary Incontinence Devices Market by Category in 2017, The External Urinary Incontinence Devices market is expected to witness a CAGR of 12.2% during (2018 - 2024).
The Vaginal Slings market dominated the UK Urinary Incontinence Devices Market by Product in 2017, growing at a CAGR of 10.1 % during the forecast period. The Urinary Catheters market is expected to witness a CAGR of 9.3% during (2018 - 2024). Additionally, The Other Devices market is expected to witness highest CAGR of 9.2% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, and Zephyr Surgical Implants
By Incontinence Type
Unique Offerings from KBV Research